PRESENTATIONS
January 2010 Corporate Update
20 - Jan - 2010
Dr. Alan Moore ,  President & CEO
Calgary ,  AB

Assessing the safety and efficacy of prolactin in EAE: A step towards a clinical trial of prolactin in MS
11 - Sep - 2009
Dr. V. Wee Yong ,  Hotchkiss Brain Institute, University of Calgary
Dusseldorf ,  Germany

STOCK QUOTE
Symbol:
TSX:SSS
Last Trade: 0.065
Change: +8.33%
Volume: 243549
Date: 9/3/2010
Time: 3:48pm

Note: Quotes are delayed. For informational purposes only.

LETTER TO SHAREHOLDERS
+ 2009 Letter to Shareholders
FACT SHEET
©2004 - 2010 Stem Cell Therapeutics - All rights reserved